Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Current Opinion in HIV and AIDS|April 18, 2009
Interactions between non-nucleoside reverse transcriptase inhibitor and nucleoside reverse transcriptase inhibitor mutations: phenotypes and mechanismsNancy S ShulmanAIDS (London, England)|April 11, 2006
Reverse transcriptase mutations 118I, 208Y, and 215Y cause HIV-1 hypersusceptibility to non-nucleoside reverse transcriptase inhibitorsShauna A Clark, Nancy S Shulman, Ronald J Bosch, et al.AIDS (London, England)|August 19, 2004
Genetic correlates of efavirenz hypersusceptibilityNancy S Shulman, Ronald J Bosch, John W Mellors, et al.Antimicrobial Agents and Chemotherapy|August 11, 2010
Maternal-fetal pharmacokinetics and dynamics of a single intrapartum dose of maraviroc in rhesus macaquesMark A Winters, Koen K A Van Rompay, Angela D M Kashuba, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2004
Detection of minority populations of HIV-1 expressing the K103N resistance mutation in patients failing nevirapineDenise Lecossier, Nancy S Shulman, Laurence Morand-Joubert, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2005
Nonnucleoside reverse transcriptase inhibitor phenotypic hypersusceptibility can be demonstrated in different assaysNancy S Shulman, Jamael Delgado, Ronald J Bosch, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 24, 2002
Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patientsNancy S Shulman, Michael D Hughes, Mark A Winters, et al.Antiviral Therapy|February 6, 2004
Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistanceJoel E Gallant, Peter Z Gerondelis, Mark A Wainberg, et al.European Journal of Gastroenterology & Hepatology|May 16, 2018
Ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin for chronic hepatitis C virus genotype 1b-infected cirrhotics (TURQUOISE-IV)Vasily Isakov, Dzmitry Paduta, Rolando M Viani, et al.The Journal of Infectious Diseases|March 23, 2017
TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on DarunavirDavid Wyles, Michael Saag, Rolando M Viani, et al.Pageof 3